Symptomatic strictures related to Crohn s disease may respond to immunosuppressive drug therapy, with improvements in symptoms and stricture morphology, according to results of a study from Australia.
Vedolizumab s effects in the intestines have led to concerns that the antibody could increase the risk of C difficile infection in patients with ulcerative colitis.
The majority of patients with inflammatory bowel disease develop a humoral immune response after completing an mRNA SARS-CoV-2 vaccine series, a new study finds.